Scholarlink

Background <p>This study primarily aimed to identify independent predictors of ICU mortality among adult patients with microbiologically confirmed carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) infection. Secondary objectives included characterization of infection types, antimicrobial resistance patterns, and ICU length of stay within this CRKP cohort.</p> Methods <p>This retrospective study included 180 adult ICU patients with microbiologically confirmed CRKP infection between January 2020 and December 2024. Demographic and clinical variables—including comorbidities, vasopressor use, mechanical ventilation, septic shock, and ICU length of stay—were extracted from electronic hospital records. Antimicrobial regimens and susceptibility profiles were recorded. Univariate and multivariate logistic regression analyses were used to determine independent predictors of mortality.</p> Results <p>The overall ICU mortality rate was 75% (135/180). Non-survivors were significantly older than survivors (75 vs. 61 years, <i>p</i> = 0.003). Vasopressor use (83.7% vs. 24.4%, <i>p</i> = 0.001) and mechanical ventilation (99.3% vs. 75.6%, <i>p</i> = 0.001) were markedly more common among non-survivors. Multivariate analysis identified age (OR 1.04; <i>p</i> = 0.001), vasopressor use (OR 13.42; <i>p</i> = 0.0001), and mechanical ventilation (OR 14.19; <i>p</i> = 0.018) as independent predictors of mortality. ROC analysis showed good discriminatory performance for vasopressor use (AUC 0.810), mechanical ventilation (AUC 0.780), and age ≥ 68 years (AUC 0.720). No statistically significant association between specific antimicrobial combination regimens and survival was observed.</p> Conclusions <p>CRKP infections in the ICU are associated with extremely high mortality, primarily driven by advanced age and acute clinical severity indicators. In this cohort, antimicrobial regimen type was not independently associated with survival, although treatment subgroup sizes were limited. Early identification of high-risk patients and optimization of supportive care remain critical.</p> Clinical trial number <p>Not applicable.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Determinants of mortality in carbapenem-resistant Klebsiella pneumoniae ICU Infections: a multivariable clinical and predictive modeling analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月9日

查看全文
  • Davut Ipek,
  • Yusuf Ipek

摘要

Background

This study primarily aimed to identify independent predictors of ICU mortality among adult patients with microbiologically confirmed carbapenem-resistant Klebsiella pneumoniae (CRKP) infection. Secondary objectives included characterization of infection types, antimicrobial resistance patterns, and ICU length of stay within this CRKP cohort.

Methods

This retrospective study included 180 adult ICU patients with microbiologically confirmed CRKP infection between January 2020 and December 2024. Demographic and clinical variables—including comorbidities, vasopressor use, mechanical ventilation, septic shock, and ICU length of stay—were extracted from electronic hospital records. Antimicrobial regimens and susceptibility profiles were recorded. Univariate and multivariate logistic regression analyses were used to determine independent predictors of mortality.

Results

The overall ICU mortality rate was 75% (135/180). Non-survivors were significantly older than survivors (75 vs. 61 years, p = 0.003). Vasopressor use (83.7% vs. 24.4%, p = 0.001) and mechanical ventilation (99.3% vs. 75.6%, p = 0.001) were markedly more common among non-survivors. Multivariate analysis identified age (OR 1.04; p = 0.001), vasopressor use (OR 13.42; p = 0.0001), and mechanical ventilation (OR 14.19; p = 0.018) as independent predictors of mortality. ROC analysis showed good discriminatory performance for vasopressor use (AUC 0.810), mechanical ventilation (AUC 0.780), and age ≥ 68 years (AUC 0.720). No statistically significant association between specific antimicrobial combination regimens and survival was observed.

Conclusions

CRKP infections in the ICU are associated with extremely high mortality, primarily driven by advanced age and acute clinical severity indicators. In this cohort, antimicrobial regimen type was not independently associated with survival, although treatment subgroup sizes were limited. Early identification of high-risk patients and optimization of supportive care remain critical.

Clinical trial number

Not applicable.

Graphical Abstract